DepoMed, Inc. (DEPO) Tops Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts DEPO Hot Sheet
Join SI Premium – FREE
DepoMed, Inc. (NASDAQ: DEPO) reported Q3 EPS of ($0.15), $0.07 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $16.52 million versus the consensus estimate of $10.4 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SLM (SLM) Tops Q1 EPS by 20c; offers guidance
- Plexus Corp (PLXS) Tops Q2 EPS by 7c
- Methanex (MEOH) Tops Q1 EPS by 35c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
